Aer Therapeutics, an Irish-founded biopharmaceutical spin-out company developing treatments for lung disease, has announced the close of a $36m Series A funding round today (14 April).

Source: https://biztoc.com/x/3959a35649fc91d3?ref=ff

An ad for the Spanish food devliery service Vicio, which has just received 17 million euros in Series A funding, led by Iris Ventures.

Source: https://wwd.com/business-news/financial/iris-ventures-leads-investment-top-spanish-food-delivery-startup-vicio-1235602724/

Commons Clinic, a startup that combines outpatient surgery centers with a care delivery model for orthopedic surgery, a $19.5M Series A round led by RA Capital Management.

Source: https://www.forbes.com/sites/alexknapp/2023/10/11/innovationrx-israel-makes-up-8-of-tevas-global-production/

Ellington’s existing Series A preferred shares provide just under 8% in dividend yield, but should the company not call them next October, the dividend will float to three-month LIBOR plus 5.196%.

Source: https://seekingalpha.com/article/4573581-ellington-financial-preferred-15-percent-ytc-11-percent-dividend-yield?source=feed_all_articles

Established in 2021, The Exploration Company has achieved an extraordinary milestone by raising $44 million this year, a record Series A for a European space startup.

Source: https://spacenews.com/revealing-the-startup-of-the-year-finalists-for-the-spacenews-2023-icon-awards/

If we continue to see valuations rising for startups raising seed rounds while later-stage prices dip, how long will it be until the journey from seed to Series A becomes one that sees companies losing value?

Source: https://techcrunch.com/2023/05/17/rising-seed-stage-valuations/

In this article, we take a look at a number of floating-rate preferreds such as the U.S. Bancorp Series A (), which are trading at yields north of 7%.

Source: https://seekingalpha.com/article/4573053-us-bancorp-7-percent-plus-yielding-preferreds-geared-for-uplift?source=feed_all_articles

Perhaps that’s why Berlin-based startup has now raised a €10.8 million ($11.6 million) Series A for its design platform that it claims allows people to “easily turn ideas into graphic products.”

Source: https://techcrunch.com/2023/01/26/this-startup-hopes-to-take-on-canva-raising-a-11-6m-series-a-for-its-design-platform/

Shanghai CirCode Biomed has closed a Series A financing round co-led by Johnson & Johnson Innovation and an undisclosed investor.

Source: https://seekingalpha.com/article/4631359-week-in-review-a-consortium-of-china-drug-distributors-want-to-acquire-polands-neuca?source=feed_all_articles

There is no separate risk pool, but instead either Series 1 or Series A or something similar acts as the risk pool.

Source: https://www.forbes.com/sites/jayadkisson/2023/10/28/abusive-captive-tax-shelters-continue-to-be-sold-despite-irs-efforts/

The Series A funding will also enable SiPhox Health to expand its team of 30 people in the areas of biology, scientists, engineers and mechanical engineers and expand its current business offerings.

Source: https://techcrunch.com/2023/07/19/intel-khosla-27m-siphox-health-at-home-blood-test-healthcare/

Warsaw-based Vue Storefront, which lets front-end developers build composable e-commerce sites, raised a $20M Series A extension led by Felix Capitaltechcrunch.

Source: https://biztoc.com/x/345c6305d051bd0c?ref=ff

While the firm is still focused on seed and early-stage funding for promising startups, the Opportunity Fund will seek to back follow-on investments for portfolio companies that are raising Series A and Series B rounds.

Source: https://www.timesofisrael.com/israels-cyberstarts-closes-480m-fund-for-cybersecurity-investments/